Zelgen Biopharma Gets Nod to Trial Small Cell Cancer Drug Combination; Shares Up 5%

MT NewswiresApr 21 03:04 ET

Zelgen Biopharmaceuticals' Loss Narrows in 2024; Shares Up 5%

MT NewswiresApr 21 02:05 ET

Zejing Pharmaceutical\'s 2025 First Quarter Report

SZSIApr 18 12:00 ET · Announcements

Zejing Pharmaceutical 2024 Annual Report

SZSIApr 18 12:00 ET · Announcements

Summary of the 2024 Annual Report of Zejing Pharmaceutical

SZSIApr 18 12:00 ET · Announcements

Zhongjing Pharmaceutical (688266.SH) released its 2024 annual performance, with a net loss attributable to shareholders of 0.138 billion yuan, a narrowing of losses.

Zhejiang ZJ Pharmaceuticals (688266.SH) released its annual report for 2024, with revenue for the year reaching 5....

Zhitong FinanceApr 18 09:52 ET